BioAssay, by Gene target for Gene (Select 5058) - PubChem BioAssay - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Links from Gene

Items: 1 to 20 of 68

<< First< Prev

Page of 4

Select item 12592671.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (GP5D)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:9 Active, 794 Tested

AID:: 1259267

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592592.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW1463)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:9 Active, 794 Tested

AID:: 1259259

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592603.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (NCIH716)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:13 Active, 794 Tested

AID:: 1259260

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592614.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCC2998)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:10 Active, 794 Tested

AID:: 1259261

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592625.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (LS513)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:93 Active, 160 Tested

AID:: 1259262

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592636.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (SW1463)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:101 Active, 160 Tested

AID:: 1259263

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592647.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CL40)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:15 Active, 794 Tested

AID:: 1259264

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592658.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (SW620)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:31 Active, 160 Tested

AID:: 1259265

Summary PubMed Citation Related BioAssays by Depositor

Select item 12592669.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS123)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:16 Active, 794 Tested

AID:: 1259266

Summary PubMed Citation Related BioAssays by Depositor

Select item 125925810.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (SW48)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:40 Active, 160 Tested

AID:: 1259258

Summary PubMed Citation Related BioAssays by Depositor

Select item 125926811.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (SNUC1)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:58 Active, 160 Tested

AID:: 1259268

Summary PubMed Citation Related BioAssays by Depositor

Select item 125926912.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (HCC2998)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:108 Active, 160 Tested

AID:: 1259269

Summary PubMed Citation Related BioAssays by Depositor

Select item 125927013.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (SNUC5)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:76 Active, 160 Tested

AID:: 1259270

Summary PubMed Citation Related BioAssays by Depositor

Select item 125927114.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (RKO)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:124 Active, 160 Tested

AID:: 1259271

Summary PubMed Citation Related BioAssays by Depositor

Select item 125927215.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW1116)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:7 Active, 794 Tested

AID:: 1259272

Summary PubMed Citation Related BioAssays by Depositor

Select item 125927316.

A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (NCIH630)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:36 Active, 160 Tested

AID:: 1259273

Summary PubMed Citation Related BioAssays by Depositor

Select item 125927417.

A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RKO)

Source:: Cancer Functional Genomics, Wellcome Trust Sanger Institute

Assay data:11 Active, 794 Tested

AID:: 1259274

Summary PubMed Citation Related BioAssays by Depositor

Select item 74345418.

RNAi screen for vorinostat resistance genes - Primary Screen

Source:: Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre

Assay data:450 Active, 18118 Tested

AID:: 743454

Summary PubMed Citation

Select item 162219.

RNAi Global Initiative pilot viability screen of human kinase and cell cycle genes

Source:: Dharmacon, a Horizon Discovery Group company

Assay data:5 Active, 840 Tested

AID:: 1622

Select item 190420.

siRNA Circadian Assay

Source:: The Genomics Institute of the Novartis Research Foundation (GNF)

Assay data:527 Active, 33364 Tested

AID:: 1904

Summary PubMed Citation Related BioAssays by Depositor

<< First< Prev

Page of 4

Supplemental Content

Filters: Manage Filters

Refine your results

• What's this?

Target

RNAi Target, Active (8)
BioAssays with gene sequences specified as RNAi targets and the activity is active

BioActivity

Active Compounds (1)
BioAssays with compounds reported as biologically active

Experiment Type

Summary (1)
BioAssays summarizing information from multiple assays for validated chemical probes or small molecule leads
Primary Screening (63)
Primary high-throughput BioAssays where the activity outcome is based on percentage inhibition from a single dose
Chemical Screens (1)
BioAssays reporting BioActivity of chemical reagents
RNAi Screens (67)
BioAssays reporting BioActivity of RNAi reagents

Assay Project (1)
BioAssays organized into assay projects based on linkage to Summary assays. Click an project below to retrieve the bioassay list for the project. Click 'All Assay Projects' to retrieve all assay projects represented by Summary assays.

Depositor Category

NIH MLP (1)
BioAssays deposited by the NIH Molecular Libraries Program
Other (66)
BioAssays deposited by other experimentalists

Actions on your results

View or Download BioAssay in PubChem

Find related data

Recent activity

Clear Turn Off Turn On

BioAssay, by Gene target for Gene (Select 5058) (68)
PubChem BioAssay
ESS2 ess-2 splicing factor homolog [Homo sapiens]
ESS2 ess-2 splicing factor homolog [Homo sapiens]
Gene ID:8220

Gene
LRRC46 leucine rich repeat containing 46 [Homo sapiens]
LRRC46 leucine rich repeat containing 46 [Homo sapiens]
Gene ID:90506

Gene
PDCL phosducin like [Homo sapiens]
PDCL phosducin like [Homo sapiens]
Gene ID:5082

Gene
INO80D INO80 complex subunit D [Homo sapiens]
INO80D INO80 complex subunit D [Homo sapiens]
Gene ID:54891

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Chemicals & Bioassays > PubChem BioAssay